SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-049103
Filing Date
2014-06-27
Accepted
2014-06-27 16:05:27
Documents
11
Period of Report
2014-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-16097_18k.htm 8-K 24717
2 EX-99.1 a14-16097_1ex99d1.htm EX-99.1 612029
3 GRAPHIC g160971mm13i001.jpg GRAPHIC 28971
4 GRAPHIC g160971mm11i001.jpg GRAPHIC 62095
5 GRAPHIC g160971mm11i002.jpg GRAPHIC 52971
6 GRAPHIC g160971mm11i003.jpg GRAPHIC 56097
7 GRAPHIC g160971mm11i004.jpg GRAPHIC 70532
8 GRAPHIC g160971mm11i005.jpg GRAPHIC 17189
9 GRAPHIC g160971mm01i001.jpg GRAPHIC 3579
10 GRAPHIC g160971mm09i001.jpg GRAPHIC 45227
11 GRAPHIC g160971mm09i002.jpg GRAPHIC 36157
  Complete submission text file 0001104659-14-049103.txt   1152931
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 14946034
SIC: 2834 Pharmaceutical Preparations